quantisnow
FeedTopReportsPricing
⌘K
Live feed
07:45:00·38d
PRRelease
Integra LifeSciences Holdings Corporation logo
Neuronetics Inc. logo
Tactile Systems Technology Inc. logo

Neuronetics Appoints Dan Reuvers as President and Chief Executive Officer

IART· Integra LifeSciences Holdings CorporationSTIM· Neuronetics Inc.TCMD· Tactile Systems Technology Inc.
Health Care
Original source

Companies

  • IART
    Integra LifeSciences Holdings Corporation
    Health Care
  • STIM
    Neuronetics Inc.
    Health Care
  • TCMD
    Tactile Systems Technology Inc.
    Health Care

Recent analyst ratings

  • Apr 15IARTUpdateArgus-
  • Jan 5TCMDUpdatePiper Sandler$35.00
  • Nov 4TCMDUpdateBTIG Research$28.00
  • Oct 3TCMDUpdateLake Street$23.50
  • May 6TCMDUpdatePiper Sandler$14.00
  • Mar 31IARTUpdateArgus-

Related

  • INSIDER2d
    SEC Form 4 filed by Chernett Jorey
  • PR3d
    Neuronetics to Report First Quarter 2026 Financial and Operating Results and Host Conference Call
  • PR3d
    Tactile Medical to Release First Quarter of Fiscal Year 2026 Financial Results on May 4, 2026
  • PR4d
    Integra LifeSciences to Host First Quarter 2026 Financial Results Conference Call on May 5, 2026
  • SEC8d
    Integra LifeSciences Holdings Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement
  • ANALYST9d
    Integra downgraded by Argus
  • PR11d
    Optum/United Healthcare/United Behavioral Health Expands NeuroStar® TMS Coverage to Include Psychiatric Mental Health Nurse Practitioners
  • SEC11d
    SEC Form EFFECT filed by Neuronetics Inc.
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022